Interestingly, resting memory B cells, characterized by frequencies of CD19+CD20+CD10-IgD-CD38-CD21+CD27+ cells were significantly decreased in moderate and severe COVID-19 both HD and non-HD patients (Figures 5G, H). This evidence concerns the gene CR2 and Huntington disease.